Event Schedule
Some people are natural born leaders, possessing traits such as self-confidence, extroversion, and high emotional intelligence. However, not every person who becomes a leader has these traits and not every person who has these traits becomes a leader. So, what are the key qualities that distinguish great MSL leaders?
  • Identify the skills and attributes of successful medical affairs leaders
  • Leverage the diversity of backgrounds and experiences within your team
  • Share educational resources for MSL leaders and aspiring leaders
Since the pandemic, medical affairs leaders have been challenged with finding creative ways to onboard new MSLs and develop comradery in a virtual setting.
  • Create a win-win scenario in onboarding – how to train new hires while developing current team members
  • It takes a village – how to incorporate all members of your field based medical team in the onboarding process
  • Empower teams to build relationships and comradery within the organization
Career paths for MSLs can sometimes be hard to navigate. Some MSLs feel stuck in their role and believe they may be limited in their options for career advancement unless they are willing to relocate. With more positions available in the field, what can MSLs do to set themselves up for their next role?
  • Define your career objectives and set actionable goals for professional development
  • Select and engage mentors who can help you achieve your goals
  • Position your skills to show value to the organizations
One of the most exciting things about field medical is how the role continues to evolve. As MSLs continue to adapt to new digital technologies and a more hybrid role, there are several best practices that will ensure success. Join our panel of MSLs and medical affairs leaders as they share their tips for success.
  • Address best practices and core competencies in field medical
  • Review global MSL practices for KOL outreach and engagement
  • Explore different field medical roles and their functions
Medical Affairs leaders agree that virtual interviews will continue post-pandemic. From testing out technologies in advance to dressing the part, what can MSLs do to make certain they ace their next virtual interview?
  • Set a checklist to ensure preparedness
  • Develop a confident and engaging room presence
  • Treat your interview like a KOL meeting
The MSL role is entirely scientific and non-promotional making it difficult for many organizations to evaluate the effectiveness of field medical teams. Companies are starting to move away from standard quantitative metrics, and now rely on holistic approaches for measuring the impact the field medical team.
  • Present the value of an MSL organization to leadership
  • Educate MSLs on the KPIs they will be evaluated on and the importance of each metric
  • Assign a value to virtual engagements
  • Allow MSLs to contribute to defining a strategy that shows their worth
Face-to-face interactions are making a comeback; however, many practitioners may want to continue to engage virtually. MSLs can continue to build upon their virtual meeting skills to ensure that they are having meaningful and impactful conversations.
  • Maintain awareness of your surroundings during virtual engagements
  • Emphasize spatial design and professional presentation during video conference
  • Best practices to maximize the capabilities of your virtual platform
With so much uncertainty surrounding the pandemic, MSLs are challenged with building and maintaining many of their relationships virtually. While MSLs are experts in communicating complex scientific data, many struggle to add their personal touch and keep virtual engagements conversational.
  • Understand the needs of the HCP and what drives their decisions
  • Develop content that is engaging and encourages HCPs to ask questions and provide insights
  • Incorporate empathy and emotional intelligence in each virtual engagement
  • Reshape data into a patient-centric narrative
MSLs have recently taken on a greater role in all stages of a product lifecycle from clinical development to post-launch. Many organizations are also engaging MSLs in project work that aligns with the medical affairs strategy.
  • Understand the diverse projects MSLs are engaged in at different companies
  • Leverage the diversity and field experience of MSLs in strategic organizational projects
  • Best practices and scenarios that inspire brainstorming and spur creative ideas
Access to KOLs and institutions is always a major challenge for MSLs and field medical professionals. In this uncertain environment, MSLs need to identify and build credibility with new KOLs to engage them in robust scientific discussions.
  • Unique ways to connect and solidify relationships with KOLs when there is no pre-existing relationship
  • Develop a methodical approach to territory management
  • Demonstrate impact and prove MSL value beyond the first meeting
From trendy Tik-Toks to discussing the latest study on Twitter, nearly two-thirds of HCPs utilize some form of social media for professional reasons. Social media presents an incredible opportunity for MSLs gain insights from traditional KOLs and the newer DOLs.
  • Determine which channels and approaches are most effective in generating insights
  • Review best practices for identifying and engaging with digital opinion leaders
  • Address compliance concerns that arise from social media interactions
As managed care organizations become more interested in the science behind a therapeutic, companies depend on their expert field medical teams to communicate the value proposition of the drug/device to payer groups. These roles may be siloed at some organizations; however, there are significant opportunities for synergy between medical and HEOR teams.
  • Define the subtle nuances between traditional MSLs and MVL/MCLs
  • Understand payer trends and balance messaging to emphasize HEOR data
  • Bridge gaps and establish ongoing relationships with payer organizations
A key metric for most field medical teams is the quantity of KOLs engagements. However, MSLs need to bring back relevant and actionable insights from these meetings to provide value to their organization.
  • Understand the gap between insights and information
  • Review effective insight-gathering methods to optimize MSL performance
  • Interpret and communicate insights to internal stakeholders (commercial, market access, etc.) in a meaningful manner
Despite unprecedented challenges with the pandemic, the FDA did not slow down their efforts in reviewing and approving new therapies. According to the Center for Drug Evaluation and Research (CDER), there were a total of 53 novel drugs approved in 2020, the second highest count in over 20 years. MSLs and medical affairs teams need to appropriately align their resources to prepare for a successful launch.
  • Best practices and tips for success from successful virtual launches
  • Train and build enthusiasm within the team when a live launch meeting is not feasible
  • Define your KOL universe and territory management plan